Frederick Millard
Papers
1
Total Citations
41
H-Index
1
About
Frederick Millard is a leading oncologic surgeon whose research focuses on the surgical management of renal cell carcinoma, particularly the complex challenge of inferior vena caval (IVC) tumor thrombus. His most impactful work, a 2019 multicenter comparative analysis, demonstrated that neoadjuvant sunitinib therapy can significantly decrease IVC thrombus size before surgery, a finding that has reshaped preoperative strategies for advanced kidney cancer. With over 40 citations, this study established a new paradigm for combining targeted therapy with aggressive surgical resection to improve oncologic outcomes. Millard’s contributions extend beyond this landmark paper; he is recognized for advancing multidisciplinary approaches that integrate systemic therapies with high-risk surgical techniques. His research has directly influenced clinical guidelines, offering patients with locally advanced disease a pathway to more favorable prognoses. Through collaborative multicenter studies, Millard continues to drive innovation in urologic oncology, bridging the gap between medical and surgical treatments to optimize survival and quality of life for those facing the most aggressive forms of kidney cancer.
Research Focus
Key Achievements
Top Papers
- 1